Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Instil Bio, Inc. Director's Dealing 2021

Mar 23, 2021

33728_dirs_2021-03-22_98e1fd3f-3086-4bd0-ba2b-c918c6d02f9c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Instil Bio, Inc. (TIL)
CIK: 0001789769
Period of Report: 2021-03-18

Reporting Person: McGaughy R Kent Jr (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-03-18 Stock Option (right to buy) $20.00 A 52000 Acquired 2031-03-18 Common Stock (52000) Direct

Footnotes

F1: The option will vest in 36 equal monthly installments commencing on April 18, 2021, subject to the Report Person's continued service as a director through the vesting date.